Пембронекст
Active substance: pembrolizumab
концентрат для приготовления раствора для инфузий, 25 мг/мл, 4 мл (original in Russian, GRLS)
RussiaActive
Marketing holder: Общество с ограниченной ответственностью "Медицинские инновации и технологии"
Verified 2026-10-09 · GRLS (Russian state register)
Analogues in other countries- Source: GRLS (Russian state register)
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 3 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2fb5-7493-aaf6-87deadc33226,01a120c3-3388-7819-8a90-9907cf3783eb,01a120c3-3389-76b8-9bad-30c2d2cc6c3c,01a120c3-86ec-7d42-aa41-0bc89a79f388,01a120c3-dbb6-7730-bfdb-0a8fefa113b6;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-1eaf-71ab-838d-9c5e76e769fc;count=1 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- ЛП-008887
- Registration status
- Active
- Dispensing
- Prescription only
- Release forms
- концентрат для приготовления раствора для инфузий, 25 мг/мл, 4 мл - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
- product · GRLS (Russian state register) · ЛП-008887 · Verified 2026-10-09
- registration_status · GRLS (Russian state register) · ЛП-008887 · Verified 2026-10-09
- ingredients.0 · GRLS (Russian state register) · ЛП-008887 · Verified 2026-10-09